‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug March 28, 2022 Auto Bot News 0 ‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drug aliu Mon, 03/28/2022 – 10:36
